Post-approval research—Phases IIIb and IV clinical trials, registries, post-market surveillance and other studies—present unique automation opportunities and challenges for study sponsors.

Medidata helps life science companies generate insights to protect their market investments through their late phase research studies. Medidata Rave®, with its scalable, configurable and easy-to-deploy structure, reduces risk and redundancies in the study process and provides analysis and trending data to explore new market opportunities, improve surveillance and track outcomes. Building on Medidata's dynamic system for electronic data capture (EDC) within a scalable, secure infrastructure, Medidata Rave for Late Phase brings the easy-to-use, globally accessible, regulatory-compliant platform and Medidata's experienced support and implementation services to the decision makers and users of late phase clinical trials and registries.